EIT Health

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advanced stage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.

Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.

MOWOOT is a Non-pharmacological & Non-invasive solution for people suffering from chronic constipation. Its solution is a wearable medical device, which provides an automatic colon-specific massage similar to the manual abdominal massage administered by health professionals. MOWOOT utilizes advanced pneumatic technology to treat and prevent chronic slow transit constipation without colon cleansing supplements, enemas, and laxatives. The company emerged out of the MOEBIO dHEALTH program, which is inspired by Stanford Biodesign and Kaospilot Design and Business School from Denmark. MOWOOT was founded in 2014 and is based in Barcelona, Spain.

Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.

ABLE Human Motion SL, founded in 2018 and based in Barcelona, Spain, is a medical device company focused on developing robotic exoskeletons for individuals with lower-limb paralysis. Originating as a spin-off from Universitat Politècnica de Catalunya, the company aims to enhance the mobility and independence of people with disabilities. Its innovative technology employs a motor and gearbox that simulate muscle function, along with an inertial sensor to interpret the user's intentions. This approach not only empowers individuals in wheelchairs by improving their mobility but also serves as a valuable tool for clinicians to enhance rehabilitation efficiency.

Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.

ABLE Human Motion SL, founded in 2018 and based in Barcelona, Spain, is a medical device company focused on developing robotic exoskeletons for individuals with lower-limb paralysis. Originating as a spin-off from Universitat Politècnica de Catalunya, the company aims to enhance the mobility and independence of people with disabilities. Its innovative technology employs a motor and gearbox that simulate muscle function, along with an inertial sensor to interpret the user's intentions. This approach not only empowers individuals in wheelchairs by improving their mobility but also serves as a valuable tool for clinicians to enhance rehabilitation efficiency.

RemAb Therapeutics specializes in the development of polymeric glycoconjugate molecules aimed at addressing nosocomial infections. The company's innovative technology focuses on eliminating non-neutralizing natural antibodies that hinder the immune system's natural response and promote pathogen proliferation. By targeting these antibodies, RemAb Therapeutics seeks to provide medical practitioners with effective new strategies for both treating and preventing a range of pathological infections, enhancing patient outcomes in the process.

Biel Glasses, SL, founded in 2017 and based in Barcelona, Spain, specializes in developing and selling electronic smart glasses designed to enhance the mobility and personal autonomy of individuals with low vision. Recognizing that low vision is more prevalent than blindness and cannot be rectified with conventional glasses or surgery, the company focuses on addressing the mobility challenges faced by this population. The smart glasses utilize 3D vision and artificial intelligence algorithms to detect obstacles, while incorporating mixed reality technology to present information in a manner accessible to users' remaining vision. Additional features such as zoom and image enhancement provide a comprehensive solution aimed at improving the quality of life for those with low vision.

GlyCardial Diagnostics S.L. develops point-of-care device that detects abnormal levels of Apo J-Glyc protein in the blood. It provides an accurate test to allow healthcare decisions. The company also develops a biomarker to detect ischaemic attack before it happens and address unmet medical need to identify patients at risk of having a repeat cardiovascular event. GlyCardial Diagnostics S.L. was founded in 2017 and is based in Barcelona, Spain.

Rethink Medical is a medical company focused on developing innovative solutions to address various health challenges. The company aims to create new remedies and enhance existing medical technologies. Its initial product, the T-Control Urinary Catheter, exemplifies this mission by improving patient care and comfort in urinary management. Rethink Medical operates within the medical device sector, striving to deliver effective and user-friendly healthcare products.

Aelix Therapeutics SL is a biotechnology company based in Barcelona, Spain, focused on developing therapeutic vaccines and immunotherapies for the treatment of HIV infection. Established in 2015, Aelix Therapeutics emerged as a spin-off from HIVACAT, a Catalan initiative aimed at creating effective HIV vaccines. The company is led by a team of experienced professionals in the fields of HIV and biotechnology, including Dr. Christian Brander, Bonaventura Clotet, Josep Maria Gatell, and Jordi Naval. Aelix Therapeutics leverages innovative immunogen designs to enhance its therapeutic approaches and has established partnerships that provide access to extensive cohorts of HIV-infected patients across various continents, facilitating clinical research and development. The company's vaccine strategy is based on a T-cell immunogen that has the potential to elicit strong immune responses, aiming to transform the treatment landscape for HIV and improve patient outcomes.

Onalabs is the first non-invasive monitoring solution measuring any chemical parameters present in sweat using miniaturized biosensors. It provides Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care. Its non-invasive products based on wearable formats empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments.

AVX Pharma is a biopharmaceutical company dedicated to developing innovative treatments for significant ophthalmic unmet medical needs, particularly ocular surface diseases. Founded in July 2013, the company emerged from neurobiological research led by Professor Carlos Belmonte at the Instituto de Neurociencias de Alicante. Based in Barcelona, AVX Pharma specializes in creating advanced medicinal products aimed at improving recovery times for conditions such as dry eye syndrome, thereby enhancing patient outcomes in the field of ophthalmology.